Carlos Montalvo Bonilla
Pulmonary Disease Physician in Arecibo, Puerto Rico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,271 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Carlos Montalvo Bonilla filed 11,585 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in Arecibo, Puerto Rico, prescribing 0% generic.
- 12K
- Part D claims, 2023
- 0%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Carlos Montalvo Bonilla's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
11,585 Top 2% higher than 98% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Carlos Montalvo Bonilla practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Carlos Montalvo Bonilla?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Puerto Rico
How Pulmonary Disease Physician compares to other specialties among Puerto Rico providers
Pulmonary Disease Physician ranks #69 among Puerto Rico's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the Puerto Rico provider total, by primary NUCC taxonomy. The highlighted bar is Pulmonary Disease Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Carlos Montalvo Bonilla appears in the CMS NPPES registry as a Pulmonary Disease Physician provider at 51 CALLE GAUTIER BENITEZ, Arecibo, PR, 00612, with a listed phone of (787) 880-1020. NPI 1972572782 was issued on 03/15/2006.
Medicare Part D records for calendar year 2023 show 11,585 prescription claims written by this provider, covering 1,293 Medicare beneficiaries and totaling roughly $3.8 million in drug spend, split 55% brand-name and 0% generic by claim count.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1972572782 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Gender | Male |
| NPI Issued | 03/15/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Carlos Montalvo Bonilla's current license status, disciplinary history, and board certifications directly with the licensing state's medical board before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1972572782 is the unique 10-digit identifier CMS uses to link Montalvo Bonilla across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Carlos Montalvo Bonilla bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Carlos Montalvo Bonilla. Source: openpaymentsdata.cms.gov.
Total received
$218
Largest payer
Medtronic, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
55% brand-name claims vs 0% generic, on 11,585 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 12,311
- Total Day Supply
- 357,962
- Brand vs Generic
- 55% brand / 0% generic
- Brand Drug Cost
- $3.6M
- Antibiotic Claims
- 80
Patient Demographics
- Average Patient Age
- 70.9 years
- Avg HCC Risk Score
- 2.49
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 313, 65-74: 474, 75-84: 409, 85+: 97
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Carlos Montalvo Bonilla prescribes most
Top Medicare Part D drugs by claim count, 2023
- Breo Ellipta
Breo Ellipta
1,537 claims
- Trelegy Ellipta
Trelegy Ellipta
1,468 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
1,195 claims
- Fluticasone Propio…
Fluticasone Propionate
1,150 claims
- Montelukast Sodium
Montelukast Sodium
994 claims
- Stiolto Respimat
Stiolto Respimat
864 claims
- Wixela Inhub 400
Wixela Inhub
400 claims
- Spiriva Respimat 269
Spiriva Respimat
269 claims
| Drug | Claims |
|---|---|
| Breo Ellipta Fluticasone/Vilanterol | 1,537 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,468 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,195 |
| Fluticasone Propionate | 1,150 |
| Montelukast Sodium | 994 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 864 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 400 |
| Spiriva Respimat Tiotropium Bromide | 269 |
| Prednisone | 258 |
| Symbicort Budesonide/Formoterol Fumarate | 246 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Carlos Montalvo Bonilla fits within the Pulmonary Disease Physician landscape nationally.
Carlos Montalvo Bonilla's 11,585 claims are above the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in Puerto Rico
Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as Montalvo Bonilla.
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Puerto Rico medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Puerto Rico
Frequently Asked Questions
What is Carlos Montalvo Bonilla's specialty? ▼
How much does Carlos Montalvo Bonilla prescribe under Medicare Part D? ▼
Where is Carlos Montalvo Bonilla located? ▼
What is Carlos Montalvo Bonilla's NPI number? ▼
Does Carlos Montalvo Bonilla prescribe more brand-name or generic drugs? ▼
How many Pulmonary Disease Physician providers are there in the US? ▼
What drugs does Carlos Montalvo Bonilla prescribe most often? ▼
Does Carlos Montalvo Bonilla accept Medicare? ▼
How can I verify Carlos Montalvo Bonilla's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology